Single-atom–doped piezocatalyst induces copper-free cuproptosis in tumor therapy
Science Advances · 14.02.2025 · 11 (7)
DOI: 10.1126/sciadv.adt8451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 14.02.2025. Verfasst von Meixiang Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, P. R. China. Hauptthemen laut MEDLINE: Copper, Molybdenum, Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cuproptosis, a distinct cell death pathway, has been integrated into nanomedicine for disease theranostics. However, current nanosystems inducing cuproptosis rely on exogenous toxic copper ions, limiting the scope of biomaterials. Developing nanoplatforms that induce cuproptosis without exogenous copper holds substantial promise. Here, we engineered a two-dimensional iron (Fe) single-atom–doped molybdenum disulfide (MoS 2 ) piezocatalyst (Fe-MoS 2 ) for tumor therapy. Incorporating single Fe atoms enhances MoS 2 piezoelectric polarization via charge redistribution and modulates Fe and Mo oxidation states, enabling multifaceted enzymatic activities, including peroxidase-, glutathione oxidase–, oxidase-, and catalase-like activities. Upon ultrasound stimulation, the Fe-MoS 2 nanocatalyst generates reactive oxygen species and depletes glutathione via synergistic piezocatalytic and enzyocatalytic effects, disrupting copper ion homeostasis and inducing cuproptosis, concurrently triggering ferroptosis and ferritinophagy, which collectively enhances tumor suppression. This study represents the first paradigm to introduce a copper-free piezocatalyst for initiating cuproptosis, substantially advancing the applications of cuproptosis in tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, P. R. China.
- Materdicine Laboratory, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.
- Anhui University of Science and Technology. School of Medicine, Huainan, Anhui 232000, P.R. China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute of Shanghai University, Wenzhou, Zhejiang 325088, P. R. China.
- Shanghai Institute of Materdicine, Shanghai 200051, P. R. China.
- College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P. R. China.
ORCID-Profile: Meixiang Zhang, Yu Qin, Yuanyuan Peng, Wei Feng, Hui Huang, Yu Chen, Jianqiao Zhou
Zitieren
APA
Zhang, M., Song, X., Qin, Y., Peng, Y., Zhang, S., Feng, W., Huang, H., Chen, Y., & Zhou, J. (2025). Single-atom–doped piezocatalyst induces copper-free cuproptosis in tumor therapy. Science Advances, 11(7). https://doi.org/10.1126/sciadv.adt8451
Vancouver
Zhang M, Song X, Qin Y, Peng Y, Zhang S, Feng W, et al. Single-atom–doped piezocatalyst induces copper-free cuproptosis in tumor therapy. Science Advances. 2025;11(7). doi:10.1126/sciadv.adt8451
BibTeX
@article{Zhang2025,
author = {Zhang, Meixiang and Song, Xinran and Qin, Yu and Peng, Yuanyuan and Zhang, Shanshan and Feng, Wei and Huang, Hui and Chen, Yu and Zhou, Jianqiao},
title = {Single-atom–doped piezocatalyst induces copper-free cuproptosis in tumor therapy},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {7},
doi = {10.1126/sciadv.adt8451}
}
EUVIMED